Short Summary
Merus N.V appealed the rejection of its Indian Patent Application No. 467/CHENP/2011 by the Assistant Controller, which had been based on non-patentability grounds (Section 3(i) and 3(j)). The appellant argued that the amendments were permissible as they merely refined the claim to nucleic acid molecules while retaining the core invention. The High Court found merit in the appellant's argument regarding the scope of amendments.
Detailed Summary
When a patent application hits a wall at the examiner's desk, the instinct is often to abandon ship. But what if the rejection itself reveals a path forward — one that requires sharpening your claims rather than scrapping them? The dispute between Merus N.V. and the Assistant Controller of Patents is a masterclass in how the right kind of amendment can turn a refused application into a granted patent. For founders navigating the choppy waters of IP prosecution, this case offers a critical lesson: the line between permissible refinement and impermissible expansion is thinner than you think, and knowing where it lies can make or break your invention.
Merus N.V., a biotech innovator, found itself at an impasse with the Indian Patent Office over its Patent Application No. 467/CHENP/2011. The Assistant Controller of Patents had rejected the application on the grounds of non-patentability under Section 3(i) and Section 3(j) of the Indian Patents Act — provisions that exclude certain categories of inventions from protection. Rather than accept the rejection, Merus N.V. chose to fight, escalating the matter to the High Court. At the heart of the dispute was a pivotal question: had Merus overstepped by amending its claims during prosecution, or had it simply refined the scope to address the Controller's objections while preserving the essence of its invention?
Merus N.V. argued that the amendments it introduced during prosecution were not a wholesale rewrite of the application but a careful narrowing of the claims — specifically, a refinement directed toward nucleic acid molecules. According to the appellant, this refinement retained the core invention intact while addressing the substantive objections raised by the Controller. The implication was clear: Merus was not trying to sneak in new matter; it was trying to meet the patentability requirements head-on. The respondent, the Assistant Controller, stood by the rejection, presumably contending that the amendments either broadened the scope beyond what was originally disclosed or failed to overcome the fundamental non-patentability objections under Sections 3(i) and 3(j). The legal friction centered on a classic prosecution dilemma: where is the boundary between legitimate claim refinement and impermissible alteration?
The High Court sided with Merus N.V., finding merit in the appellant's argument that the amendments fell within the permissible scope of prosecution refinements. The court accepted that narrowing claims to nucleic acid molecules was a legitimate response to the Controller's objections and did not constitute an impermissible departure from the original disclosure. By recognizing that the amendments preserved the core invention while addressing the patentability concerns, the court effectively reversed the rejection. The outcome was a clear win for the patent applicant — a reminder that the judiciary will look beyond the surface of a rejection to assess whether amendments genuinely serve the prosecution process or overreach it.
For founders and IP professionals, this case delivers a sharp, practical lesson: amendments during patent prosecution are not inherently suspect. If you face a rejection, the right move may be to refine your claims — narrowing scope, clarifying language, or focusing on specific embodiments — rather than abandoning the application. The key is ensuring that every amendment stays within the boundaries of your original disclosure and retains the core inventive concept. Before amending, ask yourself: does this change address the examiner's objection, or does it introduce new matter? If the former, you are on solid ground. Document your reasoning, tie each amendment to the original specification, and you may turn a rejection into a granted patent — just as Merus N.V. did.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in Merus N.V vs Assistant Controller of Patents and Designs, Government of India is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.